(Q33537860)

English

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

27 July 2017

1 reference

Europe PubMed Central

title

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia (English)

1 reference

stated in

Europe PubMed Central

27 July 2017

0 references

0 references

1

J D Jentsch

1 reference

stated in

Europe PubMed Central

27 July 2017

R H Roth

2

1 reference

stated in

Europe PubMed Central

PubMed ID

10063482

retrieved

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

stated in

Europe PubMed Central

27 July 2017

Neuropsychopharmacology

1 reference

stated in

Europe PubMed Central

27 July 2017

20

1 reference

stated in

Europe PubMed Central

27 July 2017

201-225

1 reference

stated in

Europe PubMed Central

27 July 2017

3

1 reference

stated in

Europe PubMed Central

27 July 2017

https://scigraph.springernature.com/pub.10.1016/s0893-133x(98)00060-8

0 references

Identifiers

DOI

10.1016/S0893-133X(98)00060-8

1 reference

stated in

Europe PubMed Central

PubMed ID

10063482

retrieved

27 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

PubMed ID

10063482

retrieved

27 July 2017

(Q33537860)

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)